Cost of Revenue Trends: Johnson & Johnson vs Walgreens Boots Alliance, Inc.

Comparing cost trends of two industry giants over a decade.

__timestampJohnson & JohnsonWalgreens Boots Alliance, Inc.
Wednesday, January 1, 20142274600000054823000000
Thursday, January 1, 20152153600000076691000000
Friday, January 1, 20162168500000087477000000
Sunday, January 1, 20172535400000089052000000
Monday, January 1, 201827091000000100745000000
Tuesday, January 1, 20192755600000091915000000
Wednesday, January 1, 20202842700000095905000000
Friday, January 1, 202123402000000104442000000
Saturday, January 1, 202224596000000104437000000
Sunday, January 1, 202326553000000112009000000
Monday, January 1, 202427471000000121134000000
Loading chart...

Igniting the spark of knowledge

Cost of Revenue: A Tale of Two Giants

In the ever-evolving landscape of the healthcare and retail sectors, Johnson & Johnson and Walgreens Boots Alliance, Inc. stand as titans. From 2014 to 2023, these companies have showcased distinct trends in their cost of revenue. Johnson & Johnson, a leader in pharmaceuticals and consumer health products, saw a steady increase in costs, peaking in 2020 with a 32% rise from 2014. Meanwhile, Walgreens Boots Alliance, a retail pharmacy powerhouse, experienced a more dramatic surge, with costs nearly doubling by 2023. This reflects their aggressive expansion and adaptation strategies. Notably, 2024 data for Johnson & Johnson is missing, hinting at potential shifts or reporting delays. As these giants navigate the complexities of their industries, understanding their financial trajectories offers valuable insights into their strategic priorities and market dynamics.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025